Resources
Explore our growing body of resources and research from across the women’s health innovation ecosystem.
Explore
2024
DNA-sensing pathways in health, autoinflammatory and autoimmune diseases
Dong & Fitzgerald
Summarizes DNA-sensing pathways, their regulation, roles in host defense, and how their dysregulation contributes to autoinflammatory and autoimmune diseases, including therapeutic strategies.
2024
Economic Burden Of Community-Acquired Antibiotic-resistant Urinary Tract Infections: Systematic Review And Meta-analysis
Zhu et al.
Synthesizes evidence on the economic, clinical, and health system burden of antibiotic-resistant community-acquired urinary tract infections to inform resource prioritization and intervention evaluation.
2022
Effect of Gender on Clinical Presentation Of Tuberculosis (TB) and Age-Specific Risk of TB, and TB-Human Immunodeficiency Virus Coinfection
Humayun, M. et al.
Provides data on gender differences in TB incidence, clinical presentation, and TB-HIV coinfection in Harare, Zimbabwe, to inform targeted interventions.
2024
Effect of implementation of the WHO intrapartum care model on maternal and neonatal outcomes: a randomized control trial
Abdolalipour et al.
Summarizes effects of implementing the WHO intrapartum care model on maternal and neonatal outcomes to improve childbirth experience and care quality.
2024
Effectiveness of MenB-4C Vaccine Against Gonorrhea: A Systematic Review and Meta-analysis
Abara et al.
Summarizes published data on MenB-4C vaccine effectiveness against gonorrhea, including pooled estimates, duration of protection, and implications for vaccine development.
2008
Effects of Maternal Mortality on Gross Domestic Product (GDP) in the WHO African Region
Kirigia, J. M. et al.
Estimates and analyzes the negative impact of maternal mortality on GDP in the WHO African Region to inform policy and economic advocacy.
2024
Efficacy of Semaglutide by Sex in Obesity-Related Heart Failure With Preserved Ejection Fraction: STEP-HFpEF Trials
Verma et al.
Summarizes recent advances in cardiovascular disease management, providing clinical data and recommendations to guide evidence-based patient care decisions.
2025
Eliminating HPV-related Cervical Cancer: the Role of Preventive Vaccine R&D
Impact Global Health
Summarizes global HPV vaccine R&D funding, key funders, and progress toward cervical cancer elimination to inform investment and policy decisions.
2024
Elinzanetant, A New Combined Neurokinin-1/-3 Receptor Antagonist For The Treatment Of Postmenopausal Vasomotor Symptoms
Hager et al.
Summarizes clinical data, safety, and efficacy of Elinzanetant, a neurokinin-1/-3 antagonist, for non-hormonal treatment of postmenopausal vasomotor symptoms and sleep disturbances.
2006
Emerging Infections and Pregnancy
Jamieson, D. J. et al.
Summarizes how pregnancy alters immune response, increasing susceptibility and severity of emerging infectious diseases, to inform clinical and public health planning.
2006
Emerging Infectious Determinants of Chronic Diseases
O’Connor, S. M. et al.
Summarizes evidence linking infectious agents to chronic diseases, outlines mechanisms involved, and highlights implications for prevention and public health research.
2022
Endometriosis is Undervalued: A Call To Action
Ellis, K. et al.
Summarizes the burden, funding gaps, and current and emerging diagnostic and treatment options for endometriosis to advocate for increased research investment.
Funding Opportunities
Curated global opportunities relevant to women’s health outcomes.
This list is not meant to be comprehensive — reach out if you are aware of relevant opportunities we should add. Updated every two weeks.
| Funder | Opportunity | Type | Focus | Deadline ↕ |
|---|---|---|---|---|
| Loading opportunities... | ||||
We’d love to hear from you.